Khurem Farooq is the founder of Gyroscope Therapeutics. Gyroscope Therapeutics has raised $148M in total funding. Latest round: Series C.
Khurem Farooq is the Chief Executive Officer of Gyroscope Therapeutics, a clinical-stage gene therapy company focused on treating diseases of the eye. He announced the company's $148 million Series C financing, which will be used to advance the clinical development of GT005, an investigational gene therapy for geographic atrophy.
Full founder directory · Investor directory · Company funding database · Fundraising library